- Home
- CTSO vs JZXN Comparison
CTSO vs JZXN Comparison
Compare CTSO & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- JZXN
- Stock Information
- Founded
- CTSO 1997
- JZXN 2019
- Country
- CTSO United States
- JZXN China
- Employees
- CTSO N/A
- JZXN N/A
- Industry
- CTSO Medical/Dental Instruments
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- CTSO Health Care
- JZXN Consumer Discretionary
- Exchange
- CTSO Nasdaq
- JZXN Nasdaq
- Market Cap
- CTSO 61.7M
- JZXN 51.8M
- IPO Year
- CTSO N/A
- JZXN 2021
- Fundamental
- Price
- CTSO $0.90
- JZXN $1.00
- Analyst Decision
- CTSO Buy
- JZXN
- Analyst Count
- CTSO 2
- JZXN 0
- Target Price
- CTSO $5.50
- JZXN N/A
- AVG Volume (30 Days)
- CTSO 130.7K
- JZXN 248.5K
- Earning Date
- CTSO 11-06-2025
- JZXN 03-05-2026
- Dividend Yield
- CTSO N/A
- JZXN N/A
- EPS Growth
- CTSO N/A
- JZXN N/A
- EPS
- CTSO N/A
- JZXN N/A
- Revenue
- CTSO $36,107,520.00
- JZXN $97,465.00
- Revenue This Year
- CTSO $11.93
- JZXN N/A
- Revenue Next Year
- CTSO $21.22
- JZXN N/A
- P/E Ratio
- CTSO N/A
- JZXN N/A
- Revenue Growth
- CTSO 20.18
- JZXN N/A
- 52 Week Low
- CTSO $0.71
- JZXN $0.78
- 52 Week High
- CTSO $1.61
- JZXN $7.82
- Technical
- Relative Strength Index (RSI)
- CTSO 42.05
- JZXN 54.31
- Support Level
- CTSO $0.87
- JZXN $0.95
- Resistance Level
- CTSO $1.04
- JZXN $1.11
- Average True Range (ATR)
- CTSO 0.05
- JZXN 0.07
- MACD
- CTSO -0.00
- JZXN 0.03
- Stochastic Oscillator
- CTSO 21.95
- JZXN 64.71
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.